Dibekacin
An aminoglycoside antibiotic
Dibekacin | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Dibekacin is an aminoglycoside antibiotic used in the treatment of various bacterial infections. It is particularly effective against Gram-negative bacteria and is often used in clinical settings where other antibiotics may not be effective.
Mechanism of Action[edit | edit source]
Dibekacin works by binding to the 30S subunit of the bacterial ribosome, inhibiting protein synthesis. This action is bactericidal, meaning it kills bacteria rather than merely inhibiting their growth. The binding interferes with the initiation complex of peptide formation, causing misreading of mRNA, which leads to the production of nonfunctional or toxic peptides.
Clinical Uses[edit | edit source]
Dibekacin is primarily used to treat serious infections caused by susceptible strains of bacteria. These include:
It is often reserved for use in hospital settings due to its potential for nephrotoxicity and ototoxicity, which are common side effects of aminoglycosides.
Administration[edit | edit source]
Dibekacin is usually administered via intravenous or intramuscular injection. The dosage and duration of treatment depend on the severity of the infection, the patient's renal function, and the susceptibility of the causative organism.
Side Effects[edit | edit source]
Common side effects of dibekacin include:
Patients receiving dibekacin should be monitored for signs of renal impairment and auditory damage. Dosage adjustments may be necessary in patients with pre-existing renal conditions.
Resistance[edit | edit source]
Bacterial resistance to dibekacin can occur through several mechanisms, including:
- Enzymatic modification of the drug
- Alteration of the ribosomal binding site
- Efflux pumps that remove the drug from the bacterial cell
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD